FDA Drug Application (202418) for LAMIVUDINE AND ZIDOVUDINE by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number202418
Product Number001
FormTABLET;ORAL
Dosage150MG;300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLAMIVUDINE AND ZIDOVUDINE
Active IngredientLAMIVUDINE; ZIDOVUDINE

Active IngredientCount
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient ZIDOVUDINE17


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD